Institut Català de la Salut
[Arévalos V, Ortega-Paz L] Department of Cardiology, Clinic Cardiovascular Institute, Hospital Universitari Clinic, Barcelona, Spain. [Fernandez-Rodríguez D] Department of Cardiology, Hospital Universitari Arnau de Vilanova, Lérida, Spain. [Jiménez-Díaz VA] Department of Cardiology, Hospital Universitario de Vigo, Vigo, Spain. [Rius JB] Servei de Cardiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Campo G] Department of Cardiology, Azienda Ospedaliero-Universitaria di Ferrara, Ferrara, Italy
Vall d'Hebron Barcelona Hospital Campus
2022-03-22T14:18:27Z
2022-03-22T14:18:27Z
2021-07-29
COVID-19; Cardiologia; Pronòstic
COVID-19; Cardiología; Pronóstico
COVID 19; Cardiology; Prognosis
Background Patients presenting with the coronavirus-2019 disease (COVID-19) may have a high risk of cardiovascular adverse events, including death from cardiovascular causes. The long-term cardiovascular outcomes of these patients are entirely unknown. We aim to perform a registry of patients who have undergone a diagnostic nasopharyngeal swab for SARS-CoV-2 and to determine their long-term cardiovascular outcomes. Study and design This is a multicenter, observational, retrospective registry to be conducted at 17 centers in Spain and Italy (ClinicalTrials.gov number: NCT04359927). Consecutive patients older than 18 years, who underwent a real-time reverse transcriptase-polymerase chain reaction (RT-PCR) for SARS-CoV2 in the participating institutions, will be included since March 2020, to August 2020. Patients will be classified into two groups, according to the results of the RT-PCR: COVID-19 positive or negative. The primary outcome will be cardiovascular mortality at 1 year. The secondary outcomes will be acute myocardial infarction, stroke, heart failure hospitalization, pulmonary embolism, and serious cardiac arrhythmias, at 1 year. Outcomes will be compared between the two groups. Events will be adjudicated by an independent clinical event committee. Conclusion The results of this registry will contribute to a better understanding of the long-term cardiovascular implications of the COVID19.
SB. Research grant (COV20/00040) from the Carlos III Institute, Madrid, Spain.
Article
Published version
English
COVID-19 (Malaltia) - Complicacions; Virologia; Sistema cardiovascular - Malalties; ANATOMY::Cardiovascular System; Other subheadings::Other subheadings::Other subheadings::Other subheadings::/virology; DISEASES::Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections; Other subheadings::Other subheadings::Other subheadings::/complications; ANATOMÍA::sistema cardiovascular; Otros calificadores::Otros calificadores::Otros calificadores::Otros calificadores::/virología; ENFERMEDADES::virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus; Otros calificadores::Otros calificadores::Otros calificadores::/complicaciones
Public Library of Science
PLoS ONE;16(7)
https://doi.org/10.1371/journal.pone.0255263
Attribution 4.0 International
http://creativecommons.org/licenses/by/4.0/
Articles científics - HVH [3439]